Drugs to combat HIV are about to become cheaper in developing countries. The
multinationals Glaxo Wellcome and Hoffmann-La Roche will supply drugs at cut
rates to Uganda, Côte d’Ivoire, Chile and Vietnam in a two-year pilot
initiative organised by the Joint UN Programme on HIV/AIDS. Virco, a Belgian
diagnostics company, will train local technicians to screen patients to work out
which drugs to use. “We want to demonstrate that it is workable and
sustainable,” says Joseph Saba, the initiative’s coordinator. The extent of the
discounts is still being worked out.
More from 51¶¯Âþ
Explore the latest news, articles and features
Popular articles
Trending 51¶¯Âþ articles
1
Mathematicians stunned by AI's biggest breakthrough in mathematics yet
2
The distant world that is our best hope of finding alien life
3
Photos reveal unexpected details from the world's first atomic test
4
We may finally know why dinosaurs like T. rex evolved tiny arms
5
The Selfish Gene at 50: Why Dawkins’s evolution classic still holds up
6
How I used psychology to come back from the worst year of my life
7
The 3 things you need to know about protein, according to an expert
8
Putting CO2 into rocks and getting hydrogen out is climate double win
9
Mystery of the ancient giant stone jars of Laos may have been solved
10
CAR T-cell therapy bolstered by stiffening up cancer cells first
